维普中文期刊产品整合服务
22篇 您的检索式:作者名="HATAJI O"
    题名 作者 年代 出处 被引量
1Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation显示文摘HATAJI O YAMAKADO K NAKATSUKA A 2005Intern Med2005,44,8:1
2Radiologieal and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation 显示文摘Hataji O Yamakado K Nakatsuka A 2005Intern Med J2005,44,8:1
3Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation 显示文摘Hataji O Yamakado K Nakatsuka A 2005Intern Med2005,44,8:1
4Activation of protein C pathway in the airways显示文摘Hataji O Taguchi O Gabazza EC 2002Lung2002,180,:1
5Three-dimensional computed to- mography angiography for the preoperative evaluation of coronary artery disease in lung cancer patients显示文摘Watanabe F Hataji O Ito K 2013World J Surg Oncol2013,11,1:1
6Indacaterol Improves Daily Physical Activity in Patients with Chronic Obstructive Pul- monary Disease显示文摘Hataji O Naito M Ito K 2012Int J Chron Obstruct Pulmon Dis2012,27,8:1
7Activation ofprotein C pathway in the airways显示文摘Hataji O Taguchi O Gabazza E C 2002Lung2002,180,1:1
8Increased circulating lev-els of thrombin activatable fibrinolysis inhibitor in lung cancer pa-tients显示文摘Hataji O Taguchi O Gabazza EC et ai 2004Am Hematol2004,76,3:1
9Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease 显示文摘Fujimoto H Gabazza EC Hataji O 2003Am J Res Critical Care Med2003,167,12:1
10显示文摘Fujimoto H Gabazza EC Hataji O 2003Am J Respir Crit Care Med2003,167,12:1
11Increased cir- culating levels of thrombin-activatable fibrinolysis inhib- itor in lung cancer patients 显示文摘Hataji O Taguchi O Gabazza E C 2004Am J Hematol2004,76,3:1
12Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation显示文摘Hataji O Yamakado K Nakatsuka A 2005Intern Med2005,44,8:1
13Indacaterol improves daily physical ac- tivity in patients with chronic obstructive pulmonary disease显示文摘Hataji O Naito M ho K 2013Int J Chron Obstruct Pulmon Dis2013,8,:1
14Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor ininterstitial lung disease 显示文摘Fujimoto H Gabazza EC Hataji O 2003Am J Respir Crit Care Med2003,167,:1
15Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation 显示文摘Hataji O Yamakado K Nakatsuka A 2005Intern Med2005,44,8:1
16Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patients 显示文摘Hataji O Taguchi O Gabazza E C 2004Am J Hematol2004,,76:1
17Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease显示文摘Fujimoto H Gabazza EC Hataji O 2003Am J Res Critical Care Med2003,167,12:1
18Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor ininterstitial lung disease 显示文摘Fujimoto H Gabazza EC Hataji O 2003Am J Respir Crit Care Med2003,167,12:1
19Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patients 显示文摘Hataji O Taguehi O Gabazza EC 2004Am J Hematol2004,76,3:1
20Three-dimensional compu- ted tomography angiography for the preoperative evaluation of coronaty artery diseaes in lung cancer patients显示文摘Watanabe F Hataji O ho K 2013World J Surg Oncol2013,11,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费